Authors: MIR LM DEVAUCHELLE P QUINTINCOLONNA F DELISLE F DOLIGER S FRADELIZI D BELEHRADEK J ORLOWSKI S

Citation: Lm. Mir et al., FIRST CLINICAL-TRIAL OF CAT SOFT-TISSUE SARCOMAS TREATMENT BY ELECTROCHEMOTHERAPY, British Journal of Cancer, 76(12), 1997, pp. 1617-1622

Authors: QUINTINCOLONNA F DEVAUCHELLE P FRADELIZI D MOUROT B FAURE T KOURILSKY P ROTH C MEHTALI M

Citation: F. Quintincolonna et al., GENE-THERAPY OF SPONTANEOUS CANINE MELANOMA AND FELINE FIBROSARCOMA BY INTRATUMORAL ADMINISTRATION OF HISTOINCOMPATIBLE CELLS EXPRESSING HUMAN INTERLEUKIN-2, Gene therapy, 3(12), 1996, pp. 1104-1112

Authors: MIR LM ROTH C ORLOWSKI S QUINTINCOLONNA F FRADELIZI D BELEHRADEK J KOURILSKY P

Citation: Lm. Mir et al., SYSTEMIC ANTITUMOR EFFECTS OF ELECTROCHEMOTHERAPY COMBINED WITH HISTOINCOMPATIBLE CELLS SECRETING INTERLEUKIN-2, Journal of immunotherapy with emphasis on tumor immunology, 17(1), 1995, pp. 30-38

Authors: LEBELBINAY S LAGUERRE B QUINTINCOLONNA F CONJEAUD H MAGAZIN M MILOUX B PECCEU F CAPUT D FERRARA P FRADELIZI D

Citation: S. Lebelbinay et al., EXPERIMENTAL GENE-THERAPY OF CANCER USING TUMOR-CELLS ENGINEERED TO SECRETE INTERLEUKIN-13, European Journal of Immunology, 25(8), 1995, pp. 2340-2348

Authors: ROTH C QUINTINCOLONNA F DEVAUCHELLE P KOURILSKY P

Citation: C. Roth et al., GENETICALLY-MODIFIED CELLS AS VECTORS FOR LOCAL-DELIVERY OF CYTOKINES- PROSPECTS IN ANTITUMOR IMMUNOTHERAPY, Bulletin du cancer, 82(3), 1995, pp. 227-228

Authors: ROTH C QUINTINCOLONNA F DEVAUCHELLE P KOURILSKY P

Citation: C. Roth et al., CYTOKINES SECRETIONS BY GENETICALLY-MODIF IED CELLS FOR ANTITUMOR IMMUNOTHERAPY, Pathologie et biologie, 42(10), 1994, pp. 1069-1069